Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
InhaleRx Limited ( (AU:IRX) ) has shared an announcement.
InhaleRx Limited’s recent quarterly cash flow report reveals a net cash outflow from operating activities amounting to $131,000, primarily due to expenditures on research and development, staff costs, and administration. Despite these outflows, the company maintained a stable cash position with no significant cash movements in investing or financing activities, indicating a focus on sustaining operations while managing expenses.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and commercialization of inhalation-based therapies. The company primarily engages in research and development, product manufacturing, and marketing of its healthcare solutions.
YTD Price Performance: -28.57%
Average Trading Volume: 175,783
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$5.34M
See more insights into IRX stock on TipRanks’ Stock Analysis page.